Xiaolei Liu

Loss of ZNF251 stimulates NHEJ resulting in PARP inhibitor resistance in BRCA1 mutated cancer cells

T. Skorski, Zijie Feng, Xiang Yu, 2022 .

A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential

F. Jiang, Fei Guo, Qian Wang, 2022, Frontiers in Immunology.

Haploinsufficiency of ZNF251 causes DNA-PKcs-dependent resistance to PARP inhibitors in BRCA1-mutated cancer cells

T. Skorski, Zijie Feng, W. Childers, 2023, Research square.

Characterization of HZ0412a, a novel potent humanized anti-IL-6 receptor antibody that blocks IL-6R binding to gp130

Li Li, Yuelong Xu, Qian Wang, 2023, Antibody therapeutics.

The Tumor Suppressor Adenomatous Polyposis Coli (apc) Is Required for Neural Crest-Dependent Craniofacial Development in Zebrafish

Ning Li, Christopher Joachim Lengner, Alexander J. Valvezan, 2023, Journal of developmental biology.

DNA-PKcs-dependent resistance to PARP inhibitors in BRCA 1-mutated cancer cells

T. Skorski, Zijie Feng, W. Childers, 2023 .

Targeting mitophagy in SRSF2 mutant hematologic malignancies

O. Abdel-Wahab, M. Carroll, K. Lynch, 2023, bioRxiv.

A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies

Mathieu Quesnel-Vallières, D. Wallace, Jian Huang, 2024, The Journal of clinical investigation.

A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies

O. Abdel-Wahab, M. Carroll, K. Lynch, 2024, bioRxiv.